Patents
Literature
3 results about "Hepatitis D" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Hepatitis D (hepatitis delta) is a disease caused by the hepatitis D virus (HDV), a small spherical enveloped virusoid. This is one of five known hepatitis viruses: A, B, C, D, and E. HDV is considered to be a subviral satellite because it can propagate only in the presence of the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or superimposed on chronic hepatitis B or hepatitis B carrier state (superinfection).
Methylene blue for use in therapy of hepatitis b and / or hepatitis d infection
The present invention relates to the use of methylene blue in the treatment of treatment of hepatitis B (HBV) and / or hepatitis D (HDV) infection of a human patient as well as pharmaceutical compositions applicable in this treatment.
Owner:CERNY ERICH
Anti-HBsAg antibody for treating chronic hepatitis delta
PendingCN121487748AImmunoglobulins against virusesAntibody ingredientsDiseaseAntiendomysial antibodies
The invention relates to an anti-HBsAg antibody, an antibody fragment and application thereof in preventing and treating hepatitis D virus infection and related diseases. The present invention provides a method of neutralizing hepatitis delta virus infection comprising administering an effective amount of the antibody or antigen-binding fragment thereof to a patient in need thereof by injection or infusion.
Owner:MIRUM PHARMACEUTICALS INC
Application of siRNA in preparation of medicine for treating hepatitis
The invention discloses an application of siRNA (small interfering Ribonucleic Acid) in preparation of a medicine for treating hepatitis. A positive-sense strand of the siRNA has a nucleotide sequence as shown in SEQ ID NO: 1, at least 85% of bases of an antisense strand of the siRNA and the positive-sense strand are complementary, and hepatitis is hepatitis D liver or hepatitis B and hepatitis D liver. The siRNA inhibits the duplication of liver D by inhibiting the concentration of HBV S protein in vivo.
Owner:SUZHOU HEPATHERA BIOTECH CO LTD